CRISPR

When Elenoe “Crew” Smith first learned about sickle cell disease, it was part of a seventh-grade genetics lesson on passing traits — alongside the height and color of Mendel’s pea plants — from one generation to the next.

The treatments, both produced by Boston-area companies, join 32 other approved gene therapies and are approved to treat the disease in the United States.